Designing a new bispecific tandem single-chain variable fragment antibody against tumor necrosis factor-α and interleukin-23 using in silico studies for the treatment of rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1007/s00894-020-04510-5
Published Online: 2020-08-10
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Barkhordari, A.
Mahnam, K. http://orcid.org/0000-0002-9906-4957
Mirmohammad-Sadeghi, H.
Text and Data Mining valid from 2020-08-10
Version of Record valid from 2020-08-10
Article History
Received: 5 March 2020
Accepted: 5 August 2020
First Online: 10 August 2020